P483: QUANTUM-FIRST TRIAL: FLT3-ITD–SPECIFIC MEASURABLE RESIDUAL DISEASE (MRD) CLEARANCE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL

• Mark J Levis,
• Harry P. Erba,
• Pau Montesinos,
• Radovan Vrhovac,
• Elżbieta Patkowska,
• Hee-Je Kim,
• Pavel Zak,
• Po-Nan Wang,
• Jaime E. Connolly Rohrbach,
• Ken C.N. Chang,
• James Hanyok,
• LI Liu,
• Yasser Mostafa Kamel,
• Arnaud Lesegretain,
• Jorge Cortes,
• Mikkael A. Sekeres,
• Hervé Dombret,
• Sergio Amadori,
• Jianxiang Wang,
• Richard F. Schlenk,
• Alexander E. Perl

Affiliations

Mark J Levis

1 Johns Hopkins University, Baltimore, United States

Harry P. Erba

2 Duke Cancer Institute, Durham, United States

Pau Montesinos

3 La Fe University and Polytechnic Hospital, Valencia, Spain

Radovan Vrhovac

4 University Hospital Centre Zagreb, Zagreb, Croatia

Elżbieta Patkowska

5 Institute of Hematology and Blood Transfusion, Warsaw, Poland

Hee-Je Kim

6 Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Rep. of South

Pavel Zak

7 University Hospital Hradec Kralove, Hradec Kralove, Czech Republic

Po-Nan Wang

8 Chang Gung Medical Foundation, Linkou, Taiwan

Jaime E. Connolly Rohrbach

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Ken C.N. Chang

9 Daiichi Sankyo, Inc., Basking Ridge, United States

James Hanyok

9 Daiichi Sankyo, Inc., Basking Ridge, United States

LI Liu

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Yasser Mostafa Kamel

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Arnaud Lesegretain

9 Daiichi Sankyo, Inc., Basking Ridge, United States

Jorge Cortes

10 Augusta University Medical Center, Augusta, United States

Mikkael A. Sekeres

11 Sylvester Cancer Center, University of Miami Health System, Miami, United States

Hervé Dombret

12 Saint Louis Hospital, University of Paris, Paris, France

Sergio Amadori

13 Tor Vergata Polyclinic Hospital Rome, Rome, Italy

Jianxiang Wang

14 Institute of Hematology and Blood Diseases Hospital, Tianjin, China

Richard F. Schlenk

15 Heidelberg University Hospital and German Cancer Research Center, Heidelberg, Germany

Alexander E. Perl

16 University of Pennsylvania, Philadelphia